Crystal Pharmatech Installed Asia-Pacific's First Empyrean X-ray Diffraction System
Crystal Pharmatech Co., Ltd has installed a fully-equipped, high-throughput, transmission/reflection X-ray diffractometer which it has recently purchased from PANalytical B. V.
- (1888PressRelease) May 12, 2011 - The X-ray system, Empyrean, is the latest and most advanced model offered by PANalytical, just entering the market in 2010. This is the first unit of its kind in either India or China, two of the fastest growing countries in the world for pharmaceutical development. The Empyrean is fully equipped including humidity control, temperature control, and can be operated in both transmission and reflection modes. Additionally, the Empyrean can be operated with a stage designed for a 96-well plate or in the regular
flat-stage mode with a 12 plate auto-sampler.
This state-of-the-art X-ray diffractometer can detect across a wide range of angles and is ideal for small sample masses yielding exceptional sensitivity. In addition, the Empyrean is equipped with unmatched data processing and cluster analysis software. This allows information to be gained rapidly and reliably for a large volume of samples.
"This high-end Empyrean will allow Crystal Pharmatech to provide the highest quality service to our customers" explains Alex M. Chen, CEO of Crystal Pharmatech Co., Ltd. "For salt and polymorph screening, this is an optimized way to operate as reflection mode is typically not sensitive enough for small sample sizes." "Additionally, operating in the transmission mode allows us to analyze tablets for crystal form content without any alteration to tablet integrity. This is truly a step-change for the industry."
In addition to the equipment purchase deal, Crystal Pharmatech and PANalytical China entered into a long-term collaboration. As expert users of X-ray diffractometer, Crystal Pharmatech will help promote the advanced application of X-ray diffraction in pharmaceutical industry in China. "This collaboration helps us further penetrate the market in the Asia-Pacific region. We are very pleased to work with Crystal Pharmatech, the leader in providing solid state research solution" explains Mr Shilei Xue, Country Manager of PANalytical China.
About Crystal Pharmatech
Crystal Pharmatech is a technology-driven CRO that focuses on the specialized field of solid state information for active pharmaceutical ingredients and formulations. It helps its clients to discover and select the optimal solid phase for development as well as aid them in developing the best formulation based on solid, scientific understanding. It provides its clients a complete and satisfactory solution instead of merely running experiments and collecting data. For more information, visit: http://www.crystalpharmatech.com/
PANalytical is the world's leading supplier of analytical instrumentation and software for X-ray diffraction (XRD) and X-ray fluorescence spectrometry (XRF), with more than half a century of experience. The materials characterization equipment is used for scientific research and development, for industrial process control applications and for semiconductor metrology. With its headquarters in Almelo, The Netherlands, the company has an extensive sales and service network in more than 60 countries, ensuring unrivalled level of customer support. The company is certified in accordance with ISO 9001:2000 and ISO 14001. For more information, visit: http://www.panalytical.com